Merkel cell polyomavirus
Merkel cell polyomavirus (MCPyV) is a member of the Polyomaviridae family of viruses, first identified in 2008. It is known to be a significant factor in the development of Merkel cell carcinoma, a rare and aggressive form of skin cancer.
Discovery[edit]
Merkel cell polyomavirus was discovered by scientists at the University of Pittsburgh in 2008. The team, led by Dr. Patrick S. Moore and Dr. Yuan Chang, identified the virus in samples of Merkel cell carcinoma, leading to the hypothesis that MCPyV may play a role in the development of this cancer.
Characteristics[edit]
MCPyV is a small, non-enveloped virus with a circular, double-stranded DNA genome. Like other polyomaviruses, it is capable of causing both productive, lytic infections and non-productive, latent infections. The virus is believed to be widespread in the human population, with seroprevalence studies indicating that most adults have been exposed to the virus.
Association with Merkel cell carcinoma[edit]
MCPyV is found in approximately 80% of Merkel cell carcinoma cases. The virus is believed to contribute to the development of this cancer through the integration of its genome into the host cell's DNA, leading to the expression of viral oncoproteins that interfere with the cell's normal growth control mechanisms.
Prevention and treatment[edit]
There is currently no vaccine or specific antiviral treatment for MCPyV. Prevention strategies focus on reducing the risk of Merkel cell carcinoma, which includes avoiding excessive sun exposure and practicing good skin care. Treatment for MCPyV-associated Merkel cell carcinoma typically involves surgery, radiation therapy, and/or chemotherapy.
See also[edit]
-
Phylogenetic tree of polyomaviruses
-
Electron micrograph of Merkel cell polyomavirus-like particles
-
Genomic structure of Merkel cell polyomavirus
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian